Literature DB >> 19592030

Tumor-derived pancreatic stellate cells promote pancreatic cancer cell invasion through release of thrombospondin-2.

Buckminster Farrow1, David H Berger, David Rowley.   

Abstract

BACKGROUND: Tumor derived pancreatic stellate cells (TDPS) cells are key cellular components of the pancreatic tumor microenvironment. These stellate cells can release growth factors, proteases, and extracellular matrix proteins that may stimulate the spread of pancreatic cancer. We sought to determine whether TDPS cells promote the local invasion of pancreatic cancer cells and mechanisms involved.
METHODS: TDPS and panc-1 cells were grown in coculture to determine directional migration and panc-1 invasiveness was quantified using Matrigel invasion chambers, comparing TDPS cells to human foreskin fibroblasts (HFFs). ELISA was used to determine the secretion of growth factors, proteases, and extracellular matrix proteins from TDPS cells and HFFs, and then siRNAs used to knockdown expression of factors.
RESULTS: In coculture panc-1 cells migrate toward TDPS cells, creating nests of cancer cells within the stromal cells. TDPS cells promote the invasion of panc-1 cells and release thrombospondin 2 (TSP-2), whereas HFFs did not. When TSP-2 expression is reduced in TDPS cells using selective siRNAs, pancreatic cancer cell invasion was inhibited.
CONCLUSION: Tumor-derived pancreatic stellate cells stimulate pancreatic cancer cell invasion, likely through release of TSP-2. Targeting pro-invasive elements, such as TSP-2, within the tumor microenvironment may inhibit local invasion, thus permitting more patients to undergo curative resection of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19592030     DOI: 10.1016/j.jss.2009.03.040

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  16 in total

1.  Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance.

Authors:  Min Shi; Dang-Hui Yu; Ying Chen; Chen-Yan Zhao; Jing Zhang; Qing-Hua Liu; Can-Rong Ni; Ming-Hua Zhu
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

Review 2.  Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.

Authors:  Xuqi Li; Qingyong Ma; Qinhong Xu; Wanxing Duan; Jianjun Lei; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  β-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix.

Authors:  Alysia Kern Lovgren; Jeffrey J Kovacs; Ting Xie; Erin N Potts; Yuejuan Li; W Michael Foster; Jiurong Liang; Eric B Meltzer; Dianhua Jiang; Robert J Lefkowitz; Paul W Noble
Journal:  Sci Transl Med       Date:  2011-03-16       Impact factor: 17.956

4.  Osteopontin expression is associated with improved survival in patients with pancreatic adenocarcinoma.

Authors:  Amy L Collins; Jonathan Rock; Lavina Malhotra; Wendy L Frankel; Mark Bloomston
Journal:  Ann Surg Oncol       Date:  2012-03-30       Impact factor: 5.344

5.  A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.

Authors:  Amy L Collins; Sylwia Wojcik; James Liu; Wendy L Frankel; Hansjuerg Alder; Lianbo Yu; Thomas D Schmittgen; Carlo M Croce; Mark Bloomston
Journal:  Ann Surg Oncol       Date:  2013-09-18       Impact factor: 5.344

6.  CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Lei Wang; Feng Gu; Ning Ma; Lei Zhang; Jian-Min Bian; Hong-Yong Cao
Journal:  Tumour Biol       Date:  2013-04-09

Review 7.  Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.

Authors:  Marco Rusnati; Chiara Urbinati; Silvia Bonifacio; Marco Presta; Giulia Taraboletti
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-23

8.  Prognostic Impact of Thrombospodin-2 (THBS2) Overexpression on Patients with Urothelial Carcinomas of Upper Urinary Tracts and Bladders.

Authors:  I-Wei Chang; Chien-Feng Li; Victor Chia-Hsiang Lin; Hong-Lin He; Per-In Liang; Wen-Jeng Wu; Ching-Chia Li; Chun-Nung Huang
Journal:  J Cancer       Date:  2016-07-08       Impact factor: 4.207

Review 9.  Pancreatic stellate cell: Pandora's box for pancreatic disease biology.

Authors:  Ratnakar R Bynigeri; Aparna Jakkampudi; Ramaiah Jangala; Chivukula Subramanyam; Mitnala Sasikala; G Venkat Rao; D Nageshwar Reddy; Rupjyoti Talukdar
Journal:  World J Gastroenterol       Date:  2017-01-21       Impact factor: 5.742

10.  Interaction of stellate cells with pancreatic carcinoma cells.

Authors:  Hansjörg Habisch; Shaoxia Zhou; Marco Siech; Max G Bachem
Journal:  Cancers (Basel)       Date:  2010-09-09       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.